BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2025705)

  • 1. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
    Buchanan CR; Preece MA; Milner RD
    BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycaemia in adrenal insufficiency.
    Lee SC; Baranowski ES; Sakremath R; Saraff V; Mohamed Z
    Front Endocrinol (Lausanne); 2023; 14():1198519. PubMed ID: 38053731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.
    Ranke MB
    Front Endocrinol (Lausanne); 2021; 12():720419. PubMed ID: 34539573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review.
    Vajravelu ME; Tobolski J; Burrows E; Chilutti M; Xiao R; Bamba V; Willi S; Palladino A; Burnham JM; McCormack SE
    Int J Pediatr Endocrinol; 2015; 2015():22. PubMed ID: 26500680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic pitfalls in the assessment of congenital hypopituitarism.
    Cavarzere P; Biban P; Gaudino R; Perlini S; Sartore L; Chini L; Silvagni D; Antoniazzi F
    J Endocrinol Invest; 2014 Dec; 37(12):1201-9. PubMed ID: 25080869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases.
    Guillon MA; Mary PM; Brugière L; Marec-Bérard P; Pacquement HD; Schmitt C; Guinebretière JM; Tabone MD
    BMC Cancer; 2011 Sep; 11():407. PubMed ID: 21942935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth hormone therapy in adults. Attempt to assess a decade of use].
    Faust M; Strasburger CJ
    Internist (Berl); 2008 May; 49(5):527-8, 530-2, 534 passim. PubMed ID: 18418567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission barriers for bovine, ovine, and human prions in transgenic mice.
    Scott MR; Peretz D; Nguyen HO; Dearmond SJ; Prusiner SB
    J Virol; 2005 May; 79(9):5259-71. PubMed ID: 15827140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk following growth hormone use in childhood: implications for current practice.
    Ogilvy-Stuart AL; Gleeson H
    Drug Saf; 2004; 27(6):369-82. PubMed ID: 15144231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence.
    Jeffcoate W
    Drug Saf; 2002; 25(3):199-212. PubMed ID: 11945115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational approach to short stature: focus on use and abuse of growth hormone.
    Krishna J
    Indian J Pediatr; 1997; 64(2):145-52. PubMed ID: 10771830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system.
    Brandner S; Raeber A; Sailer A; Blättler T; Fischer M; Weissmann C; Aguzzi A
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13148-51. PubMed ID: 8917559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to restore scrapie prion infectivity after exposure to protein denaturants.
    Prusiner SB; Groth D; Serban A; Stahl N; Gabizon R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2793-7. PubMed ID: 8464892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to tackle a possible Creutzfeldt-Jakob disease necropsy.
    Bell JE; Ironside JW
    J Clin Pathol; 1993 Mar; 46(3):193-7. PubMed ID: 8463410
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study.
    Price DA; Johnston DI; Betts PR; Buckler JM; Donaldson MD
    Arch Dis Child; 1994 Sep; 71(3):266-71. PubMed ID: 7979506
    [No Abstract]   [Full Text] [Related]  

  • 16. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
    Telling GC; Scott M; Hsiao KK; Foster D; Yang SL; Torchia M; Sidle KC; Collinge J; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9936-40. PubMed ID: 7937921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology and pathogenesis of prion diseases.
    DeArmond SJ; Prusiner SB
    Am J Pathol; 1995 Apr; 146(4):785-811. PubMed ID: 7717447
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary growth hormone and Creutzfeldt-Jakob disease.
    Macario ME; Vaisman M; Buescu A; Moura Neto V; Araujo HM; Chagas C
    BMJ; 1991 May; 302(6785):1149. PubMed ID: 2043794
    [No Abstract]   [Full Text] [Related]  

  • 19. The spongiform encephalopathies.
    Will RG
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):761-3. PubMed ID: 1955893
    [No Abstract]   [Full Text] [Related]  

  • 20. Creutzfeldt-Jakob disease and blood transfusion.
    Contreras M; Barbara J
    BMJ; 1991 May; 302(6785):1148-9. PubMed ID: 1953852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.